NICE propose to charge £142,000 to conduct single technology appraisals from May 2017.
Read more HERE
NICE propose to charge £142,000 to conduct single technology appraisals from May 2017.
Read more HERE
Most pharmaceutical products hoping to launch in the UK will be assessed by NICE as a Single Technol...
Read moreSecuring a positive recommendation from the National Institute for Health and Care Excellence (NICE)...
Read moreBe the first to receive exclusive content on the latest from the pharmaceutical and market access sector.
Remap Consulting have significant experience working with pharmaceutical and biotech companies in helping them navigate global market access.
Get in touch